These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31090560)

  • 41. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aborted sudden cardiac death: ICD or no ICD.
    Lachmann V; Makimoto H; Kelm M; Bönner F
    Clin Res Cardiol; 2017 Sep; 106(9):760-763. PubMed ID: 28396986
    [No Abstract]   [Full Text] [Related]  

  • 43. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study.
    Anguera I; Dallaglio P; Martínez-Ferrer J; Rodríguez A; Alzueta J; Pérez-Villacastín J; Porres JM; Viñolas X; Fontenla A; Fernández-Lozano I; García-Alberola A; Sabaté X
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):774-82. PubMed ID: 25916814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ventricular Tachycardia Ablation in Patients With Implantable Cardioverter Defibrillators Should No Longer Be a Therapy of Last Resort.
    Kanagasundram AN; John RM; Stevenson WG
    Circulation; 2018 May; 137(18):1885-1887. PubMed ID: 29712693
    [No Abstract]   [Full Text] [Related]  

  • 45. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychological and quality-of-life issues in the young patient with an implantable cardioverter-defibrillator.
    DeMaso DR; Neto LB; Hirshberg J
    Heart Rhythm; 2009 Jan; 6(1):130-2. PubMed ID: 18774753
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
    Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M
    Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia.
    Napolitano C; Priori SG
    Heart Rhythm; 2007 May; 4(5):675-8. PubMed ID: 17467641
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of morphology discrimination for ventricular tachycardia diagnosis in implantable cardioverter-defibrillators.
    Theuns DA; Rivero-Ayerza M; Goedhart DM; van der Perk R; Jordaens LJ
    Heart Rhythm; 2006 Nov; 3(11):1332-8. PubMed ID: 17074640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inappropriate shocks in a patient treated with a cardioverter defibrillator.
    Hutse W; Tavernier R; Jordaens L
    Heart; 1997 Apr; 77(4):386-7. PubMed ID: 9155627
    [No Abstract]   [Full Text] [Related]  

  • 52. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS; Bianco NR; Knilans TK; Czosek RJ; Anderson JB
    Circ Arrhythm Electrophysiol; 2018 Jul; 11(7):e006163. PubMed ID: 29945928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction of ICD shock burden by eliminating back-up pacing induced ventricular tachyarrhythmias.
    Theis C; Mollnau H; Sonnenschein S; Konrad T; Himmrich E; Bock K; Schulz E; Kämpfner D; Gerhardt S; Quesada Ocete B; Münzel T; Rostock T
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):889-895. PubMed ID: 24654876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subclinical hypothyroidism: a reversible cause of complete loss of ventricular lead capture.
    Esposito F; Liguori V; Maresca G; Cerrone A; De Filippo O; Trimarco B; Rapacciuolo A
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):182-4. PubMed ID: 24550411
    [No Abstract]   [Full Text] [Related]  

  • 55. Implantable cardioverter-defibrillator detection of repolarization alternans: uncovering a marker of electrical instability.
    Christini DJ; Lerman BB
    Heart Rhythm; 2006 Jul; 3(7):798-9. PubMed ID: 16818209
    [No Abstract]   [Full Text] [Related]  

  • 56. Paced Tachycardia.
    Arias MA; Narváez I; Pachón M
    Circulation; 2020 Dec; 142(24):2389-2392. PubMed ID: 33315493
    [No Abstract]   [Full Text] [Related]  

  • 57. Impact of shock energy and ventricular rhythm on the success of first shock therapy: the ALTITUDE first shock study.
    Cha YM; Hayes DL; Asirvatham SJ; Powell BD; Cesario DA; Cao M; Gilliam FR; Jones PW; Jiang S; Saxon LA
    Heart Rhythm; 2013 May; 10(5):702-8. PubMed ID: 23337541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Sweeney MO
    Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472
    [No Abstract]   [Full Text] [Related]  

  • 59. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Noninvasive risk stratification for sudden death: signal-averaged electrocardiography, nonsustained ventricular tachycardia, heart rate variability, baroreflex sensitivity, and QRS duration.
    Stein KM
    Prog Cardiovasc Dis; 2008; 51(2):106-17. PubMed ID: 18774010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.